Problem statement: Answer the multiple-choice question.
Query: Which drug exhibits a -4.356\% hERG inhibition at 1uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
[a] Cc1ccc(S(=O)(=O)n2ccc(=O)[nH]2)cc1
[b] CC(C)n1nnnc1SCC(=O)Nc1ccc2c(c1)OCO2
Answer: b. CC(C)n1nnnc1SCC(=O)Nc1ccc2c(c1)OCO2
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CC(C)n1nnnc1SCC(=O)Nc1ccc2c(c1)OCO2
CC(C)n1nnnc1SCC(=O)Nc1ccc2c(c1)OCO2
N-(1,3-benzodioxol-5-yl)-2-(1-propan-2-yltetrazol-5-yl)sulfanylacetamide